Audax Biosciences, formerly oNKo-innate, is a leading Australian biotechnology company founded in 2018. The company is driven by a team of experts with deep immunology knowledge and a passion for long-term scientific discovery.

They specialise in advancing immunotherapies for oncology and autoimmune diseases, leveraging their in-house capabilities to pursue ambitious targets in the field. They are focused on carefully tested hypotheses rather than following trends.